Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,310
archived clinical trials in
Allergy

Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated:  10/29/2015
New York Medical College
mi
from
Valhalla, NY
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated:  10/29/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated:  10/29/2015
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated:  10/29/2015
Baylor College of Medicine
mi
from
Houston, TX
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated:  10/29/2015
Vermont Lung Center at The University of Vermont
mi
from
Burlington, VT
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Vermont Lung Center at The University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated:  10/29/2015
Univeristy of Virginia
mi
from
Charlottesville, VA
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Univeristy of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated:  10/29/2015
Louisiana State University Health Sciences Center
mi
from
New Orleans, LA
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Louisiana State University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated:  10/29/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Study of Asthma and Nasal Steroids
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Neo-Synalar Modified 48 Hour Patch Test
A Modified 48 Hour Patch Test of Neo-Synalar Cream, Sodium Lauryl Sulfate (Positive Control) and Saline (Negative Control)
Status: Enrolling
Updated:  11/5/2015
Michael Caswell PhD., CCRC,CCRA
mi
from
Fairfield, NJ
Neo-Synalar Modified 48 Hour Patch Test
A Modified 48 Hour Patch Test of Neo-Synalar Cream, Sodium Lauryl Sulfate (Positive Control) and Saline (Negative Control)
Status: Enrolling
Updated: 11/5/2015
Michael Caswell PhD., CCRC,CCRA
mi
from
Fairfield, NJ
Click here to add this to my saved trials
Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
Phase 1 Single Center, Randomized, Controlled Study Using Sublingual Immunotherapy for Timothy Grass and Dust Mite Allergies
Status: Enrolling
Updated:  11/24/2015
Stanford University
mi
from
Stanford, CA
Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
Phase 1 Single Center, Randomized, Controlled Study Using Sublingual Immunotherapy for Timothy Grass and Dust Mite Allergies
Status: Enrolling
Updated: 11/24/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated:  12/15/2015
University of Arkansas
mi
from
Little Rock, AR
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated: 12/15/2015
University of Arkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated:  12/15/2015
National Jewish Medical and Research Center
mi
from
Denver, CO
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated: 12/15/2015
National Jewish Medical and Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated:  12/15/2015
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated: 12/15/2015
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated:  12/15/2015
Mount Sinai School of Medicine
mi
from
New York, NY
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated: 12/15/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated:  12/15/2015
University of North Carolina
mi
from
Durham, NC
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract
Status: Enrolling
Updated: 12/15/2015
University of North Carolina
mi
from
Durham, NC
Click here to add this to my saved trials
Tolerance Following Peanut Oral Immunotherapy
Clinical Desensitization and Tolerance Following Peanut Oral Immunotherapy and Subsequent Allergen Avoidance
Status: Enrolling
Updated:  1/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Tolerance Following Peanut Oral Immunotherapy
Clinical Desensitization and Tolerance Following Peanut Oral Immunotherapy and Subsequent Allergen Avoidance
Status: Enrolling
Updated: 1/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma
Role of RhuMab-E25 in Reducing Exhaled NO in Allergic Asthma
Status: Enrolling
Updated:  1/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma
Role of RhuMab-E25 in Reducing Exhaled NO in Allergic Asthma
Status: Enrolling
Updated: 1/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft in Patients With a History of Allergic Conjunctivitis
Status: Enrolling
Updated:  1/26/2016
Derek Cunningham
mi
from
Austin, TX
A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft in Patients With a History of Allergic Conjunctivitis
Status: Enrolling
Updated: 1/26/2016
Derek Cunningham
mi
from
Austin, TX
Click here to add this to my saved trials
Safety of Lymph Node Injection for Allergen Immunotherapy
Phase I Study of Allergen-Specific Intralymphatic Immunotherapy in the United States
Status: Enrolling
Updated:  2/5/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Safety of Lymph Node Injection for Allergen Immunotherapy
Phase I Study of Allergen-Specific Intralymphatic Immunotherapy in the United States
Status: Enrolling
Updated: 2/5/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
SCCOR in Host Factors in Chronic Lung Diseases: Mechanisms of Immune Tolerance and Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  2/12/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
SCCOR in Host Factors in Chronic Lung Diseases: Mechanisms of Immune Tolerance and Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 2/12/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Rosedale, NY
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Rosedale, NY
Click here to add this to my saved trials
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated:  2/23/2016
Hamzavi Dermatology/Dermatology Specialists of Canton
mi
from
Canton, MI
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated: 2/23/2016
Hamzavi Dermatology/Dermatology Specialists of Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated:  2/23/2016
Hamzavi Dermatology
mi
from
Fort Gratiot, MI
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated: 2/23/2016
Hamzavi Dermatology
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated:  2/23/2016
Lynderm Research
mi
from
Markham,
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated: 2/23/2016
Lynderm Research
mi
from
Markham,
Click here to add this to my saved trials
Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Phase 2 EFFICACY AND SAFETY OF HYDROCORTISONE OPHTHALMIC OINTMENT - VERSUS PLACEBO IN THE TREATMENT OF ALLERGIC CONJUNCTIVITIS
Status: Enrolling
Updated:  2/24/2016
Koffler Vision Group
mi
from
Lexington, KY
Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Phase 2 EFFICACY AND SAFETY OF HYDROCORTISONE OPHTHALMIC OINTMENT - VERSUS PLACEBO IN THE TREATMENT OF ALLERGIC CONJUNCTIVITIS
Status: Enrolling
Updated: 2/24/2016
Koffler Vision Group
mi
from
Lexington, KY
Click here to add this to my saved trials
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
Oral Immunotherapy Combined With Humanized Monoclonal Anti-IgE Antibody Xolair® (Omalizumab)in the Treatment of Cow's Milk Allergy
Status: Enrolling
Updated:  3/8/2016
Stanford University School of Medicine
mi
from
Stanford, CA
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
Oral Immunotherapy Combined With Humanized Monoclonal Anti-IgE Antibody Xolair® (Omalizumab)in the Treatment of Cow's Milk Allergy
Status: Enrolling
Updated: 3/8/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
Oral Immunotherapy Combined With Humanized Monoclonal Anti-IgE Antibody Xolair® (Omalizumab)in the Treatment of Cow's Milk Allergy
Status: Enrolling
Updated:  3/8/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
Oral Immunotherapy Combined With Humanized Monoclonal Anti-IgE Antibody Xolair® (Omalizumab)in the Treatment of Cow's Milk Allergy
Status: Enrolling
Updated: 3/8/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
Oral Immunotherapy Combined With Humanized Monoclonal Anti-IgE Antibody Xolair® (Omalizumab)in the Treatment of Cow's Milk Allergy
Status: Enrolling
Updated:  3/8/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
Oral Immunotherapy Combined With Humanized Monoclonal Anti-IgE Antibody Xolair® (Omalizumab)in the Treatment of Cow's Milk Allergy
Status: Enrolling
Updated: 3/8/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Austin, TX
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Kerrville, TX
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Kerrville, TX
Click here to add this to my saved trials
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
New Braunfels, TX
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
San Antonio, TX
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome
Prospective Case Series Evaluating Short and Long Term Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome
Status: Enrolling
Updated:  3/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome
Prospective Case Series Evaluating Short and Long Term Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome
Status: Enrolling
Updated: 3/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Status: Enrolling
Updated:  3/18/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Status: Enrolling
Updated: 3/18/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Comparability and Standardization of Controlled Allergen Challenge Facilities
Comparability and Standardization of Controlled Allergen Challenge Facilities
Status: Enrolling
Updated:  3/21/2016
Biogenics Research Chamber
mi
from
San Antonio, TX
Comparability and Standardization of Controlled Allergen Challenge Facilities
Comparability and Standardization of Controlled Allergen Challenge Facilities
Status: Enrolling
Updated: 3/21/2016
Biogenics Research Chamber
mi
from
San Antonio, TX
Click here to add this to my saved trials
Comparability and Standardization of Controlled Allergen Challenge Facilities
Comparability and Standardization of Controlled Allergen Challenge Facilities
Status: Enrolling
Updated:  3/21/2016
Kingston General Hospital
mi
from
Kingston,
Comparability and Standardization of Controlled Allergen Challenge Facilities
Comparability and Standardization of Controlled Allergen Challenge Facilities
Status: Enrolling
Updated: 3/21/2016
Kingston General Hospital
mi
from
Kingston,
Click here to add this to my saved trials
Omalizumab in the Treatment of Peanut Allergy
Effects of Omalizumab on Peanut Allergen Induced Cellular and Clinical Responses in Peanut Allergic Adults
Status: Enrolling
Updated:  3/28/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Omalizumab in the Treatment of Peanut Allergy
Effects of Omalizumab on Peanut Allergen Induced Cellular and Clinical Responses in Peanut Allergic Adults
Status: Enrolling
Updated: 3/28/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
Status: Enrolling
Updated:  3/28/2016
Johns Hopkins University
mi
from
Baltimore, MD
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
Status: Enrolling
Updated: 3/28/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated:  4/6/2016
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated: 4/6/2016
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated:  4/6/2016
National Jewish Health
mi
from
Denver, CO
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated: 4/6/2016
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated:  4/6/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated: 4/6/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated:  4/6/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated: 4/6/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated:  4/6/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
An Observational Study of Childhood Food Allergy
A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)
Status: Enrolling
Updated: 4/6/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Allergic Rhinitis Changes the Sinus Microbiome
Allergic Rhinitis Changes the Sinus Microbiome
Status: Enrolling
Updated:  4/11/2016
University of Chicago
mi
from
Chicago, IL
Allergic Rhinitis Changes the Sinus Microbiome
Allergic Rhinitis Changes the Sinus Microbiome
Status: Enrolling
Updated: 4/11/2016
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
Concomitant Dry Eye in Patients With Ocular Allergy: an Under Recognized and Poorly Managed Syndrome
Status: Enrolling
Updated:  6/2/2016
Schwartz Laser Eye Center
mi
from
Scottsdale, AZ
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
Concomitant Dry Eye in Patients With Ocular Allergy: an Under Recognized and Poorly Managed Syndrome
Status: Enrolling
Updated: 6/2/2016
Schwartz Laser Eye Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray Versus Montelukast in Adolescents/Adults With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus(R) or Placebo
Status: Enrolling
Updated:  6/15/2016
Creighton University
mi
from
Omaha, NE
Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray Versus Montelukast in Adolescents/Adults With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus(R) or Placebo
Status: Enrolling
Updated: 6/15/2016
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Quality of Life in Food Allergic Families
Quality of Life in Food Allergic Families
Status: Enrolling
Updated:  6/29/2016
University of Michigan Allergy and Immunology Clinic
mi
from
Ann Arbor, MI
Quality of Life in Food Allergic Families
Quality of Life in Food Allergic Families
Status: Enrolling
Updated: 6/29/2016
University of Michigan Allergy and Immunology Clinic
mi
from
Ann Arbor, MI
Click here to add this to my saved trials